1. Home
  2. RYTM vs MHK Comparison

RYTM vs MHK Comparison

Compare RYTM & MHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

N/A

Current Price

$97.07

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Logo Mohawk Industries Inc.

MHK

Mohawk Industries Inc.

N/A

Current Price

$129.24

Market Cap

6.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
RYTM
MHK
Founded
2008
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.2B
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
RYTM
MHK
Price
$97.07
$129.24
Analyst Decision
Strong Buy
Buy
Analyst Count
14
11
Target Price
$131.14
$126.10
AVG Volume (30 Days)
421.1K
860.2K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
28.34
N/A
EPS
N/A
5.11
Revenue
N/A
N/A
Revenue This Year
$55.34
$3.38
Revenue Next Year
$86.06
$3.09
P/E Ratio
N/A
$24.81
Revenue Growth
N/A
N/A
52 Week Low
$74.50
$92.99
52 Week High
$122.20
$140.30

Technical Indicators

Market Signals
Indicator
RYTM
MHK
Relative Strength Index (RSI) 40.64 50.75
Support Level $99.14 $106.01
Resistance Level $113.04 $134.45
Average True Range (ATR) 3.98 3.73
MACD -0.78 -0.99
Stochastic Oscillator 19.75 52.21

Price Performance

Historical Comparison
RYTM
MHK

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About MHK Mohawk Industries Inc.

Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Global Ceramic designs, manufactures, sources, distributes and markets a broad line of ceramic, porcelain and natural stone tile products used for floor and wall applications in residential and commercial channels for both remodeling and new construction. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.

Share on Social Networks: